Health Awareness Inc | Jupiter, FL

Research site

(Unclaimed)

Location

500 University Boulevard, Suite 208, Jupiter, Florida, United States of America

Site insights

Top conditions

Top treatments

Diclofenac Sodium Gel

Buprenorphine

HYD

Estradiol

fezolinetant

Plecanatide

Canakinumab

Hydrocodone Bitartrate

X0002

Lansoprazole

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 90 total trials

New

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in...

Begins enrollment in 2 months

Metabolic Dysfunction-Associated Steatotic Liver Disease

Drug: Tirzepatide

Drug: Placebo

A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

The goal of this clinical trial is to assess the safety, reactogenicity and immunogenicity of an mRNA-based vaccine, JCXH-108, the prevention of Resp...

Active, not recruiting

Respiratory Syncytial Virus (RSV)

Infectious Disease

Other: Placebo

Biological: JCXH-108

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition (NASHGEN-2)

This study is researching an investigational drug, ALN-HSD called "study drug". This study is focused on participants who are known to have metabolic...

Enrolling

Metabolic Dysfunction-associated Steatohepatitis (MASH)

Drug: Placebo

Drug: ALN-HSD

A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis (Nova 301)

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Active, not recruiting

Acute Gastroenteritis

Norovirus Acute Gastroenteritis

Biological: mRNA-1403

Biological: Placebo

A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight

This study is open to adults who are at least 18 years old and have* presumed or confirmed NASH together with overweight or obesity and* a body mass...

Active, not recruiting

Non-Alcoholic SteatoHepatitis (NASH)

Obesity

Drug: Survodutide

Drug: Placebo

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripher...

Enrolling

Diabetic Peripheral Neuropathic Pain

Drug: Placebo (matched to pregabalin)

Drug: Placebo (matched to VX-993)

Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill

This is an estimation-focused Phase 2 study designed to explore and quantify treatment-related changes across multiple clinical outcomes in patients...

Active, not recruiting

Alzheimer Disease

Drug: MAR

Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications (NAVIGATE)

The purpose of this study is to evaluate the effectiveness of CD388 in preventing symptomatic laboratory-confirmed influenza infections, as compared...

Active, not recruiting

Influenza

Combination Product: CD388 Injection

Combination Product: Placebo